US BANCORP \DE\ - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,653
-98.5%
437
-95.5%
0.00%
Q2 2023$241,271
+582.6%
9,713
+313.3%
0.00%
Q1 2023$35,344
-86.8%
2,350
-89.6%
0.00%
Q4 2022$268,517
+1313.2%
22,698
+595.0%
0.00%
Q3 2022$19,000
+280.0%
3,266
+153.6%
0.00%
Q2 2022$5,000
-64.3%
1,288
-11.7%
0.00%
Q1 2022$14,000
+100.0%
1,458
+279.7%
0.00%
Q4 2021$7,000
-50.0%
384
-9.0%
0.00%
Q3 2021$14,000
-97.3%
422
-96.9%
0.00%
-100.0%
Q2 2021$525,000
-19.1%
13,552
+0.7%
0.00%0.0%
Q1 2021$649,000
-2.3%
13,464
+5.5%
0.00%0.0%
Q4 2020$664,000
+1444.2%
12,761
+154.2%
0.00%
Q1 2016$43,000
-28.3%
5,0200.0%0.00%
Q4 2015$60,000
+17.6%
5,0200.0%0.00%
Q3 2015$51,000
-39.3%
5,020
-1.2%
0.00%
Q2 2015$84,000
-42.9%
5,080
-46.6%
0.00%
-100.0%
Q1 2015$147,000
-3.3%
9,510
-1.2%
0.00%0.0%
Q4 2014$152,000
+32.2%
9,625
-10.7%
0.00%
Q3 2014$115,000
+13.9%
10,7750.0%0.00%
Q2 2014$101,00010,7750.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders